-+ 0.00%
-+ 0.00%
-+ 0.00%

B. Riley Securities Maintains Buy on Vaxart, Lowers Price Target to $2

Benzinga·03/27/2025 17:19:17
Listen to the news
B. Riley Securities analyst Mayank Mamtani maintains Vaxart (NASDAQ:VXRT) with a Buy and lowers the price target from $2.5 to $2.